组织陈列-产品详情

home > TISSUE ARRAYS > Baldder > UBD601b

Type
- FFPE
- FROZEN TISSUE
Identity
Organ
- Liver
- Esophagus
- Ovary
- Stomach
- Lung
- Colon
- Rectum
- Kidney
- Breast
- Endometrium
- Uterus
- Bladder
- Pancreas
- Skin
- Penis
- Testis
- Soft_Tissue
- Bone/Cartilage
- Oral/Cavity
- Bone/Marrow
- Heart
- Spleen
- Head/Neck
- Vulva
- Melanoma
- Appendix
- Intestine
- Adrenal Gland
- Thymus
- Fallopian tube
- Mouse
- Fetus
- Rat
- Monkey (Rhesus) (Normal)-RsFPT
- Monkey (Cynomolgus) (Normal)-CyFPT
- Dog
- Multiple organ
- Gall bladder and bile duct
- Esophagogastric junction
Types/Disease
Cores
Cases

Cores:

60

CASES:

60

Core Diameter(mm):

2

Thickness(µm):

5

Row number:

6

Column number:

10

Tissue Array Type:

FFPE

Species:

Human

UBD601b

$225.00

Description: Bladder cancer (stage III-IV) tissue array, including TNM and clinical stage, 60 cases/60 cores, replacing BL601a

Details: Bladder carcinoma tissue microarray, containing 60 cases of urothelial carcinoma, single core per case

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:

Unstained

H&E

Tag:

60 Cores 60 Cases Baldder special price single core per case

Add To Cart

Outright purchase

Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

Specification sheet
Overlapping case
Download specifications

Legend:

Car-Cardia Eso-Fsophagus

Malignant(III)
Malignant(IV)
_ph

TISSUE ARRAYS
UBD601b

	1	2	3	4	5	6	7	8	9	10
A	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
B	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
C	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
D	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
E	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
F	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	_ph

UBD601b

Age:
Sex:
Organ/Anatomic Site:
Pathology diagnosis:
Grade:
TNM:
Stage:
Tissue ID.:
Type:

Pos	No.	Age	Sex	Organ/Anatomic Site	Pathology diagnosis	Grade	TNM	Stage	Type
A1	1	42	F	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
A2	2	72	M	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
A3	3	66	M	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
A4	4	62	M	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
A5	5	80	M	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
A6	6	75	M	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
A7	7	72	M	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
A8	8	54	F	Bladder	Invasive urothelial carcinoma with squamous metaplasia	*	T3N0M0	III	Malignant
A9	9	70	M	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
A10	10	67	F	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
B1	11	75	F	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
B2	12	65	M	Bladder	Invasive urothelial carcinoma with squamous metaplasia	*	T3N0M0	III	Malignant
B3	13	58	M	Bladder	Invasive urothelial carcinoma with squamous metaplasia	*	T3N0M0	III	Malignant
B4	14	67	M	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
B5	15	67	M	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
B6	16	65	M	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
B7	17	74	M	Bladder	Invasive urothelial carcinoma	*	T4N0M0	III	Malignant
B8	18	57	M	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
B9	19	67	M	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
B10	20	62	M	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
C1	21	72	M	Bladder	Invasive urothelial carcinoma with squamous metaplasia	*	T3N0M0	III	Malignant
C2	22	78	M	Bladder	Invasive urothelial carcinoma with adenoid metaplasia	*	T3N0M0	III	Malignant
C3	23	38	M	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
C4	24	68	M	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
C5	25	65	F	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
C6	26	66	M	Bladder	Invasive urothelial carcinoma with sarcomatous differentiation	*	T3N0M0	III	Malignant
C7	27	64	M	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
C8	28	86	M	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
C9	29	60	M	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
C10	30	42	M	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
D1	31	54	M	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
D2	32	71	F	Bladder	Invasive urothelial carcinoma with squamous metaplasia	*	T3N0M0	III	Malignant
D3	33	60	F	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
D4	34	73	M	Bladder	Invasive urothelial carcinoma (sparse)	*	T3N0M0	III	Malignant
D5	35	74	M	Bladder	Invasive urothelial carcinoma (sparse)	*	T3N0M0	III	Malignant
D6	36	70	M	Bladder	Invasive urothelial carcinoma with squamous metaplasia	*	T3N0M0	III	Malignant
D7	37	54	F	Bladder	Invasive urothelial carcinoma	*	T2N0M0	III	Malignant
D8	38	58	M	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
D9	39	65	F	Bladder	Invasive urothelial carcinoma with adenoid metaplasia	*	T3N0M0	III	Malignant
D10	40	60	M	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
E1	41	60	M	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
E2	42	70	F	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
E3	43	65	F	Bladder	Invasive urothelial carcinoma with adenoid metaplasia	*	T3N0M0	III	Malignant
E4	44	58	M	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
E5	45	46	M	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
E6	46	60	M	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
E7	47	61	F	Bladder	Invasive urothelial carcinoma with squamous metaplasia	*	T3N0M0	III	Malignant
E8	48	59	F	Bladder	Invasive urothelial carcinoma with sarcomatous differentiation	*	T3N0M0	III	Malignant
E9	49	60	F	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
E10	50	45	M	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
F1	51	53	M	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
F2	52	71	M	Bladder	Invasive urothelial carcinoma	*	T3N0M0	III	Malignant
F3	53	52	M	Bladder	Invasive urothelial carcinoma with squamous metaplasia	*	T4N0M0	III	Malignant
F4	54	79	M	Bladder	Invasive urothelial carcinoma	*	T3N1M0	IV	Malignant
F5	55	64	M	Bladder	Invasive urothelial carcinoma	*	T3N1M0	IV	Malignant
F6	56	33	M	Bladder	Invasive urothelial carcinoma	*	T3N1M0	IV	Malignant
F7	57	64	M	Bladder	Invasive urothelial carcinoma	*	T3N1M0	IV	Malignant
F8	58	40	F	Bladder	Invasive urothelial carcinoma with squamous metaplasia	*	T3N1M0	IV	Malignant
F9	59	46	F	Bladder	Invasive urothelial carcinoma with adenoid metaplasia	*	T3N2M0	IV	Malignant
F10	60	66	M	Bladder	Invasive urothelial carcinoma	*	T4N0M0	III	Malignant
_pheochromocytoma_

Find overlapping cases with this tissue array:

UBD601b

File Format: .xlsx

Release Date: 2025-01-17 16:11:48
Download

	1	2	3	4	5	6	7	8	9	10
A	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
B	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
C	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
D	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
E	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
F	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	_ph

	1	2	3	4	5	6	7	8	9	10
A	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
B	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
C	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
D	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
E	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
F	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	_ph

	1	2	3	4	5	6	7	8	9	10
A	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
B	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
C	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
D	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
E	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
F	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	_ph